Preclinical evaluation of genetically engineered T cells designed to target solid cancers with KRAS mutations Godkjenningsdato 18.10.2024 Godkjent fra 18.10.2024 Godkjent til 17.10.2028 ALURES NTS Database ID: NTS-NO-614998